PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 4 analysts with an average price target of $18.57. This is a potential upside of $13.8 (289.31%) from yesterday's end of day stock price of $4.77.

Phathom Pharmaceuticals's activity chart (see below) currently has 31 price targets and 67 ratings on display. The stock rating distribution of PHAT is 95.83% BUY and 4.17% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.63% with an average time for these price targets to be met of 35.22 days.

Highest price target for PHAT is $28, Lowest price target is $12, average price target is $22.67.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 09-Apr-2025.

Currently out of the existing stock ratings of PHAT, 46 are a BUY (95.83%), 2 are a HOLD (4.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$28

$23.12 (473.77%)

$28

7 days ago
(09-Apr-2025)

0/42 (0%)

$23.57 (532.05%)

Buy

$15

14 days ago
(02-Apr-2025)

1/6 (16.67%)

$5.99 (66.48%)

152

Buy

$28

$23.12 (473.77%)

$28

1 months 9 days ago
(07-Mar-2025)

0/6 (0%)

$22.94 (453.36%)

Hold

$12

$7.12 (145.90%)

$10

8 months 7 days ago
(09-Aug-2024)

6/7 (85.71%)

$0.25 (2.13%)

29

Buy

$30

$25.12 (514.75%)

$35

2 years 1 months 15 days ago
(01-Mar-2023)

0/4 (0%)

$20.99 (232.96%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 35.22 days on average for the stock forecasts to be realized with a an average price target met ratio 20.63

Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

PAUL CHOI

Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Paul Choi works at GOLDMAN SACHS and has 6 price targets and 5 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with highest potential upside - $52.74

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Yatin Suneja with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?